Squarepoint’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.13M Buy
390,000
+377,700
+3,071% +$2.12M ﹤0.01% 2138
2025
Q4
$86.1K Buy
12,300
+600
+5% +$4.7K ﹤0.01% 4058
2025
Q3
$90.4K Sell
11,700
-88,700
-88% -$692K ﹤0.01% 4131
2025
Q2
$874K Sell
100,400
-42,400
-30% -$307K ﹤0.01% 2782
2025
Q1
$1.14M Buy
142,800
+43,900
+44% +$444K ﹤0.01% 2551
2024
Q4
$899K Buy
+98,900
New +$955K ﹤0.01% 3159
2024
Q3
Sell
-16,500
Closed -$161K 4692
2024
Q2
$161K Buy
+16,500
New +$201K ﹤0.01% 3712
2024
Q1
Sell
-58,400
Closed -$1.26M 4603
2023
Q4
$1.26M Buy
+58,400
New +$1.08M ﹤0.01% 2361
2023
Q3
Sell
-66,500
Closed -$1.68M 4237
2023
Q2
$1.68M Buy
66,500
+53,800
+424% +$1.35M 0.01% 1777
2023
Q1
$329K Buy
+12,700
New +$340K ﹤0.01% 2520
2022
Q1
Sell
-13,300
Closed -$1.22M 3505
2021
Q4
$1.22M Hold
13,300
﹤0.01% 1561
2021
Q3
$1.69M Hold
13,300
﹤0.01% 1291
2021
Q2
$2.21M Sell
13,300
-8,400
-39% -$1.36M 0.01% 1133
2021
Q1
$3.94M Buy
+21,700
New +$5.03M 0.02% 737

Other funds holding TDOC

Squarepoint's TDOC Position: Q3 2025 in Review

Squarepoint sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 34,000 shares — an estimated $265K sold.

Squarepoint first reported a position in TDOC in Q2 2017 and held it in 23 quarters. The position peaked at $50.6M in Q1 2022. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Squarepoint reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 34,000 Teladoc Health shares in Q3 2025, an estimated $265K.
  • Squarepoint first reported a position in Teladoc Health in Q2 2017 and held it in 23 quarters.
  • Squarepoint's Teladoc Health position peaked at $50.6M in Q1 2022.
  • 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.